Partners Calciphylaxis Biobank

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT03032835
Status
Recruiting
Apply to this trial

Conditions

  • Calcific Uremic Arteriolopathy
  • Calciphylaxis
  • Chronic Kidney Diseases
  • End Stage Renal Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Calciphylaxis, a vascular calcification disorder, is a rare and serious disorder characterized by calcification of dermal arterioles. There are significant gaps in the understanding of the pathophysiology and risk factors for calciphylaxis. At present, there is no effective treatment. Uncertain pathobiology, rare incidence and lack of collaborative approach have been some of the major limiting factors towards treating calciphylaxis. The Partners Calciphylaxis Biorepository (PCB) aims to address these gaps within calciphylaxis research by utilizing existing and, when necessary, developing new infrastructure to support the consent of patients and the collection of dedicated samples for a calciphylaxis repository.

Key Dates

Start date
Jan 31, 2017
Status verified
Nov 2024
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Study participants
    No intervention

Primary Outcome Measure

Number of patients with improvement in calciphylaxis skin lesions [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Massachusetts General HospitalBostonMassachusetts02114
Sagar U Nigwekar, MD, MMSc
[email protected]
617-726-7872

Find similar trials in Boston, MA

By research site
Massachusetts General Hospital· Boston, MA

Related Studies